The new Medicare 'Access' code for AI in chronic care is priced too low to be profitable if humans are kept in the loop. This clever incentive design forces providers to adopt genuine AI-driven leverage rather than simply relabeling human effort, a first for healthcare technology.

Dr. Wachter argues AI's rapid healthcare uptake stems from a collision of new technology with a system universally seen as failing. While consumers weren't clamoring for a better Google, everyone in healthcare—patients and providers alike—recognized the deep, unmet needs, making them receptive to a transformative solution.

Healthcare has historically been a service, with costs tied to licensed professionals. AI models like Gemini and ChatGPT are changing this by providing medical advice, effectively turning healthcare into a product. This shift, currently tolerated by regulators, could dramatically lower costs and increase access, just like software products.

AI's most significant impact won't be on broad population health management, but as a diagnostic and decision-support assistant for physicians. By analyzing an individual patient's risks and co-morbidities, AI can empower doctors to make better, earlier diagnoses, addressing the core problem of physicians lacking time for deep patient analysis.

To overcome resistance, AI in healthcare must be positioned as a tool that enhances, not replaces, the physician. The system provides a data-driven playbook of treatment options, but the final, nuanced decision rightfully remains with the doctor, fostering trust and adoption.

An effective AI strategy in healthcare is not limited to consumer-facing assistants. A critical focus is building tools to augment the clinicians themselves. An AI 'assistant' for doctors to surface information and guide decisions scales expertise and improves care quality from the inside out.

The immense regulatory complexity in U.S. healthcare creates an estimated $500 billion "tax" of administrative bloat. The non-obvious opportunity is that by using AI to eliminate this waste, the savings could be redirected to fund expanded patient care, rather than just being captured as profit.

An "AI arms race" is underway where stakeholders apply AI to broken, adversarial processes. The true transformation comes from reinventing these workflows entirely, such as moving to real-time payment adjudication where trust is pre-established, thus eliminating the core conflict that AI is currently used to fight over.

Chronic disease patients face a cascade of interconnected problems: pre-authorizations, pharmacy stockouts, and incomprehensible insurance rules. AI's potential lies in acting as an intelligent agent to navigate this complex, fragmented system on behalf of the patient, reducing waste and improving outcomes.